BIOLASE, an Irvine, Calif.-based dental laser development and distribution company, has announced that it has earned a U.S. patent covering its laser technologies as a treatment of ophthalmic conditions.
The patent, titled "Methods for Treating Eye Conditions," broadly states the technology can be used to treat eye conditions such as glaucoma, cataracts and presbyopia.
BIOLASE has a presence in the ophthalmology market with its wholly owned subsidiary OCCULASE.
More Articles on Ophthalmology:
ARVO Names Dr. Justine Smith President, Dr. William Mieler President-Elect
8 Recent Eye Surgery Center Openings, Mergers & Acquisitions
Valeant Acquires Bausch + Lomb for $8.7B
The patent, titled "Methods for Treating Eye Conditions," broadly states the technology can be used to treat eye conditions such as glaucoma, cataracts and presbyopia.
BIOLASE has a presence in the ophthalmology market with its wholly owned subsidiary OCCULASE.
More Articles on Ophthalmology:
ARVO Names Dr. Justine Smith President, Dr. William Mieler President-Elect
8 Recent Eye Surgery Center Openings, Mergers & Acquisitions
Valeant Acquires Bausch + Lomb for $8.7B